Current Drug Delivery
Title:Editorial (Hot Topic: Treatment of Inflammatory Bowel Diseases: Where Do We Go from here?)
Volume: 9 Issue: 4
Author(s): Laurent Peyrin-Biroulet
Affiliation:
Export Options
About this article
Cite this article as:
Peyrin-Biroulet Laurent, Editorial (Hot Topic: Treatment of Inflammatory Bowel Diseases: Where Do We Go from here?), Current Drug Delivery 2012; 9 (4) . https://dx.doi.org/10.2174/156720112801323099
DOI https://dx.doi.org/10.2174/156720112801323099 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway
Current Cancer Drug Targets Liposomes as Potential Carrier System for Targeted Delivery of Polyene Antibiotics
Recent Patents on Inflammation & Allergy Drug Discovery Drugs, Environmental Factors, Loci and Genes Involved in Nonsyndromic Orofacial Cleft
Current Pharmacogenomics The sdLDL Reduces MRC1 Expression Level and Secretion of Histamin e in Differentiated M2-macrophages from Patients with Coronary Artery Stenosis
Cardiovascular & Hematological Disorders-Drug Targets Chemokines as Pharmacological Targets
Mini-Reviews in Medicinal Chemistry Mechanisms of Cardioprotection of Halogenated Agents During Extracorporeal Circulation in Cardiac Surgery
Current Vascular Pharmacology Preface [Hot Topic: Advances in the Treatment of Hepatitis B and C Virus Infections (Executive Editor: Raffaele Cozzolongo)]
Current Pharmaceutical Design Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Editorial [Hot Topic:Novel Targets in Cancer Therapy(Guest Editor: Debabrata Banerjee)]
Current Pharmaceutical Biotechnology Endogenous and Exogenous Ligands of Aryl Hydrocarbon Receptor: Current State of Art
Current Drug Metabolism Importance of Fibroblasts-Myofibroblasts in Asthma-Induced Airway Remodeling
Recent Patents on Inflammation & Allergy Drug Discovery Vitiligo: Pathogenetic Hypotheses and Targets for Current Therapies
Current Drug Metabolism Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Neurosarcoidosis
Current Neuropharmacology MicroRNA Dysregulation in the Myelodysplastic Syndromes
MicroRNA COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
Current Respiratory Medicine Reviews Electronic-Topological Study of Structurally Diverse Cyclooxygenase-2 Inhibitors
Mini-Reviews in Medicinal Chemistry PROGRAMMED Cell Clearance: Molecular Mechanisms and Role in Autoimmune Disease, Chronic Inflammation, and Anti-Cancer Immune Responses
Current Immunology Reviews (Discontinued) Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Current Medicinal Chemistry